Pharsight

IONIS PHARMACEUTICALS PATENTS FACING OPPOSITIONS

Top patents of IONIS PHARMACEUTICALS facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2906696B2 14 Dec, 2022 Methods For Modulating C9Orf72 Expression NA 2
EP2701713B1 07 Feb, 2018 Modulation Of Apolipoprotein Ciii (Apociii) Expression Apr, 2032 2
EP2742135B2 10 Jun, 2020 Linkage Modified Gapped Oligomeric Compounds And Uses Thereof NA 1
EP2399588B1 29 Apr, 2020 Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase Jan, 2022 1
EP3031920B1 21 Aug, 2019 Modulation Of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression Jul, 2031 1
EP3208347B1 14 Aug, 2019 Selective Reduction Of Allelic Variants NA 1
EP3321361B1 27 Mar, 2019 Selective Reduction Of Allelic Variants NA 1
EP2640853B1 26 Dec, 2018 Modulation Of Alpha Synuclein Expression NA 1
EP2864479B1 15 Aug, 2018 Modulation Of Ube3A-Ats Expression NA 1
EP2812342B1 15 Nov, 2017 Modulation Of Rna By Repeat Targeting NA 1